The University of Cambridge and Cambridge University Hospitals have been awarded £110m to ‘boost research and allow the development of ground breaking medicines’. The funding is part of an £800 million investment by the National Institute of Health Research (NIHR) - the UK’s largest ever investment in ‘early stage’ health research.
The University of Cambridge and Cambridge University Hospitals have been awarded £110m to ‘boost research and allow the development of ground breaking medicines’. The funding is part of an £800 million investment by the National Institute of Health Research (NIHR) - the UK’s largest ever investment in ‘early stage’ health research.
Backed by the NIHR, Cambridge is currently one of just five comprehensive Biomedical Research Centres in England. The funding for the Cambridge Biomedical Research Centre (as it was designated in 2007) will be allocated over a five-year period. The money will contribute to the development of ground-breaking medicines, treatments and patient care.
In Cambridge, the money will back projects designed to benefit patients with diseases such as cancer and diabetes, specifically targeting advances in diagnosis, prevention and treatment. Additionally, the Cambridge partnership has also been awarded a new specialist Biomedical Research Unit focussed on dementia – a field in which it was identified as a national research leader.
Professor Patrick Sissons, Regius Professor of Physic, said: “The fundamental basis of our research programmes is that they are all designed to benefit patients. This award makes it possible for us to lead the way in translating fundamental biomedical research into clinical research, and ultimately into advances in healthcare that can be put into practice within the NHS and around the world.”
Dr John Bradley, director of the NIHR Cambridge Biomedical Research Centre said: “We are delighted to receive the news that we have retained our Biomedical Research Centre designation – and even more pleased that the international selection panel has recommended a considerable increase in our funding. This will allow the partnership between Cambridge University Hospitals and the University of Cambridge to build on the substantial achievements of the last five years. A renewal was never guaranteed – this was a competition with the best of England’s health research institutions.”
The 11 research themes of the Cambridge Biomedical Research Centre include: brain injury; cancer; cardiovascular disease; dementia and neurodegeneration; genomics; mental health; infectious diseases and disorders of the immune system; obesity, diabetes and musculoskeletal disorders; transplantation; population science; and women’s health. More information is available on the Cambridge Biomedical Research Centre website.
This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.